ABSTRACT
BACKGROUND
Scleredema of Buschke is an uncommon disorder characterized by induration of the skin that includes a nonpitting hardening of the skin around the neck, shoulders and trunk, thickening usually begins on the neck and later spreads to the shoulders, upper part of the trunk and sometimes the face. 1, 2 The disease was first described by Curzio in 1752, 1 Abraham Buschke in 1902 gave the condition the name scleredema. 2 Currently, the disease is simply referred to as scleredema, or scleredema of Buschke. Three variants are recognized; the first is accompanied by an acute febrile illness like influenza, tonsillitis, pharyngitis, measles, scarlet fever, mumps, otitis, furuncles, erysipelas, impetigo, etc. In most instances, the infection is of streptococcal origin and characterized by resolution over several months, the second follows a slow progressive course with no apparent underlying disease and the third is associated with diabetes mellitus. The histopathologic features of scleredema are characterized by thickened collagen bundles within the reticular dermis that are seperated by mucin containing fenestrations, the mucin is thought to represent nonsulfated acid mucopolysaccharides. These thickened collagen bundles are often more prominent within the deeper dermis. This process may extend into the subcutaneous fatty tissue.
Multiple treatment modalities for scleredema have been used, including bath psoralen UVA, 3 cyclosporine, 4 lowdose methotrexate, 5 extracorporeal photopheresis 6 and, in a case, high dose penicillin 7 was used with good prognosis.
CASE REPORT
A 10-year-old female child reported with chief complaint of stiffness of facial skin and difficulty in opening the mouth since 1 month. On medical history, no history of any drug allergy, hospitalization or any illness, but she gave a positive history for recurrent throat infection. On extraoral examination, the skin was stiff on palpation ( Fig. 1) , the stiffness was seen at temple region, scalp (Fig. 2) , bilaterally on the face and neck up to sternum, posteriorly up to C5, and the mouth opening was decreased. On intraoral examination of soft tissue, loss of stippling seen in gingiva, buccal mucosa was firm in consistency. Hematological investigation showed that the blood counts, blood sugar, blood urea, serum creatinine were within normal range and ASO titer >200 IU/ml. Histopathological examination of a skin biopsy from the neck and buccal mucosa showed (Figs 4 to 6) swelling and splitting of dermal collagen bundles by an increase in ground substance, dermis was 3 times its normal thickness, deposition of hyaluronic acid between the collagen fibers, in dermis thick collagen bundles separated by large interfibrous spaces, fibrous noncellular hyperplasia replaces large areas of subcutaneous tissue resulting in increased skin thickness, increase in acid mucopolysaccharides.
The patient was treated with antibiotics and vitamin supplements and there was drastic improvement with decrease in skin stiffness and increase in mouth opening (Table 1 and Fig. 3 ) in her follow-up visits.
DISCUSSION
Buschke in 1902 described this systemic disease with woody, nonpitting indurations of 'plaster statue' consistency starting at the nape of the neck and spreading throughout the body, usually symmetrically but sparing the palms and soles, 2 rarely the tongue, pharynx and parotid gland may also be involved, 8 there is a history of preceding infection in 65 to 90% of cases as reported in The condition is usually self-limiting with active phase persisting for 2 to 8 weeks followed by spontaneous and complete resolution in 6 months to 2 years. Occasional cases with no resolution even after 10 years have been cited. The potential chronicity and severity of the disorder should not be underestimated, as there have been at least two deaths due to scleredema. 15, 16 Histologically, scleredema shows a normal epidermis but the dermis may be three times the normal thickness with swelling and splitting of the dermal collagen bundles and variable deposition of the mucin in the dermis, histochemical analysis have shown that the amount of glycosaminoglycans and collagenase increased in the affected skin.
CONCLUSION
There is no definitive therapy for scleredema. In the mildest cases, optimization of metabolic control and physiotherapy especially in case of motion or respiratory disability are recommended. For the rare progressing forms, various systemic treatments have been proposed including corticosteroids, D-penicillamine, cyclosporine, methotrexate, PUVA therapy, prostaglandin E1, factor XIII or radiotherapy. High-dose antibiotic therapy can prove to be a useful line of treatment of this rare disorder.
CLINICAL SIGNIFICANCE
Oral symptoms of scleredema are often neglected. Patients with this disease may have difficulty in mouth opening. High-dose antibiotic therapy and vitamins may be used for treatment of scleredema with reasonably good prognosis. 
